Suggestions
Alex Belser
Chief Clinical Officer, Cybin; Psychedelic Researcher; Psychologist
Professional Background
Dr. Alexander Belser is a distinguished psychedelic researcher and psychologist currently affiliated with renowned Yale University, where he has dedicated his career over the last 20 years to advancing the field of psychedelic medicine. Notably, he has been at the forefront of numerous clinical trials investigating the efficacy of psilocybin and MDMA for treating a variety of mental health challenges such as depression, anxiety, substance use disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and end-of-life distress. His groundbreaking work has not only expanded the knowledge base within the clinical community but has also elevated the discourse surrounding psychedelic therapies on a global scale.
In addition to his research endeavors, Dr. Belser serves as the Chief Clinical Officer of Cybin Inc., one of the largest publicly traded psychedelic life sciences companies, where he plays a pivotal role in steering innovative therapeutic approaches and clinical studies. Beyond this position, he is the founding President of Nautilus Sanctuary, the pioneering non-profit center for psychedelic medicine on the East Coast, where he strives to make these transformative therapies accessible to those in need.
Dr. Belser's work has garnered significant media attention and his research has been prominently featured in esteemed publications such as the New York Times, The Atlantic, The New Yorker, The Guardian, and the influential book by Michael Pollan, "How to Change Your Mind." His insights into the potential of psychedelics in therapeutic settings have made him a sought-after speaker, leading to over fifty lectures, presentations, and Grand Rounds dedicated to the exploration of psychedelic medicine and its benefits.
Education and Achievements
Dr. Belser's extensive educational background has paved the way for his successful career in psychology and clinical research. He completed a Clinical Research Fellowship in Psychology at Yale University, where he gained invaluable insights into the practical application of psychological principles in clinical settings. He earned a Ph.D. in Counseling Psychology from New York University, demonstrating his commitment to understanding the complexities of human behavior and mental health.
His academic journey includes coursework in a Master’s Program in Clinical Psychology at Teachers College, Columbia University, alongside a Master of Philosophy in Criminological Research at the University of Cambridge. He began his academic pursuits with a Bachelor's degree in English and Government from Georgetown University, providing a well-rounded understanding of social issues and the nuances of human experience.
Dr. Belser’s commitment to ongoing education and professional development is evident through his extensive training in psychedelic psychotherapy, where he has learned from recognized senior teachers in the field. As a testament to his holistic approach to wellness, he is also a licensed kundalini and hatha yoga teacher, further integrating somatic practices into his therapeutic repertoire.
Notable Achievements
Throughout his career, Dr. Belser has authored over a dozen peer-reviewed journal articles and book chapters in the field of psychedelic medicine, contributing significantly to the literature that supports the therapeutic use of psychedelics. His involvement in influential studies, particularly as a Study Therapist in MDMA-assisted psychotherapy trials for severe PTSD, has positioned him as a key figure within the psychedelic research community. In his role as a Co-Investigator at Yale University, he has actively participated in pioneering clinical trials that seek to revolutionize treatment modalities for various mental health conditions.
His leadership extends beyond research; Dr. Belser has played an instrumental role in advisory capacities, serving on the Board of Advisors to Compass Pathways (formerly a non-profit organization) and acting as a contributing member of the Chacruna Institute’s Women, Gender Diversity, and Sexual Minorities Working Group. In this role, he diligently advocates for the rights and well-being of LGBTQI+ individuals within the context of psychedelic medicine, highlighting his commitment to social justice and health equity.
In summary, Dr. Alexander Belser's career is characterized by an unwavering dedication to advancing the field of psychedelic medicine through research, education, and advocacy. His innovative work continues to open new avenues for understanding mental health treatment, and his commitment to creating equitable access to these transformative therapies sets a precedent in the evolving landscape of psychological care.
